Robert A. Galemmo

1.6k citations

46 papers · 1.0k indexed · h-index 19

Impact in

Hematology top 10%
- Blood Coagulation and Thrombosis Mechanisms
Hepatology top 10%
- Liver physiology and pathology

Papers in

Hematology 12
- Blood Coagulation and Thrombosis Mechanisms 11
Immunology and Allergy 5
- Cell Adhesion Molecules Research 5

Co-authors: Benjamin Y. Owusu Lidija Klampfer James W. Janetka Robert M. Knabb Ruth R. Wexler Pancras C. Wong Dana L. Johnson Robert W. Tuman
Journals: Bioorganic & Medicinal Chemistry Letters (11 papers)Journal of Medicinal Chemistry (11 papers)The Journal of Organic Chemistry (3 papers)Tetrahedron Letters (2 papers)Oncotarget (2 papers)
Partner nations: United States Israel Germany

In The Last Decade

Robert A. Galemmo

45 papers receiving 964 citations

Peers

Countries citing papers authored by Robert A. Galemmo

Since Specialization

Citations

This map shows the geographic impact of Robert A. Galemmo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Galemmo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Galemmo more than expected).

Fields of papers citing papers by Robert A. Galemmo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Galemmo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Galemmo. The network helps show where Robert A. Galemmo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Robert A. Galemmo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert A. Galemmo Line = papers co-authored together Robert A. Galemmo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Design and Synthesis of Nonpeptide Inhibitors of Hepatocyte Growth Factor Activation ACS Medicinal Chemistry Letters ·F. Hinze, Benjamin Y. Owusu, Namita Bansal, Larry J. Ross, Judith V. Hobrath, Donghui Bao, Rajdeep Sharma, Murray Stackhouse, Troy E. Messick, Lidija Klampfer, Robert A. Galemmo	2015	18
2	LRRK2 secretion in exosomes is regulated by 14-3-3 Human Molecular Genetics ·K. B. Fraser, Mark S. Moehle, João Paulo Lima Daher, Olena Shcherbatiuk, 王芬娥, Charles A. Stewart, Talene A. Yacoubian, Rita M. Cowell, Terje Dokland, Tong Ye, Daxin Chen, Gene P. Siegal, Robert A. Galemmo, Elpida Tsika, Darren J. Moore, David G. Standaert, Kensuke Kojima, James A. Mobley, Andrew B. West	2013	135
3	Oral Coadministration of β-Glucuronidase to Increase Exposure of Extensively Glucuronidated Drugs that Undergo Enterohepatic Recirculation Journal of Pharmaceutical Sciences ·Gary Eichenbaum, Chyi‐Hung Hsu, Vangala Subrahmanyam, Jing Chen, Jan Scicinski, Robert A. Galemmo, Robert W. Tuman, Dana L. Johnson	2012	8
4	Studies with an Orally Bioavailable αV Integrin Antagonist in Animal Models of Ocular Vasculopathy: Retinal Neovascularization in Mice and Retinal Vascular Permeability in Diabetic Rats Journal of Pharmacology and Experimental Therapeutics ·Rosemary J. Santulli, William A. Kinney, Shyamali Ghosh, 张汨, Li Liu, Robert W. Tuman, Zhou Zhao, Norman Huebert, Sven Bursell, Lourdes María Alejandra Fernández, Maria B. Grant, Lynn C. Shaw, Shaker A. Mousa, Robert A. Galemmo, Dana L. Johnson, Bruce E. Maryanoff, Bruce P. Damiano	2007	41
5	Pyrazole-based factor Xa inhibitors containing N-arylpiperidinyl P4 residues Bioorganic & Medicinal Chemistry Letters ·Jennifer X. Qiao, Xuhong Cheng, Joanne M. Smallheer, Robert A. Galemmo, Schlenk Ralph, Donald Pinto, Daniel L. Cheney, Kan He, Pancras C. Wong, Joseph M. Luettgen, Robert M. Knabb, Ruth R. Wexler, Patrick Y. S. Lam	2006	18
6	The synthesis and SAR of 2-amino-pyrrolo[2,3-d]pyrimidines: A new class of Aurora-A kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·K.J.M. Moriarty, Holly K. Koblish, Thomas Garrabrant, Ji Qingxiang, Ehab M. Khalil, Alvarez Venegas Víctor Hugo, Ioanna P. Petrounia, Carl Crysler, Anna C. Maroney, Dana L. Johnson, Robert A. Galemmo	2006	54
7	N-GLUCURONIDATION OF THE PLATELET-DERIVED GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR 6,7-(DIMETHOXY-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-3-YL)-(3-FLUORO-PHENYL)-AMINE BY HUMAN UDP-GLUCURONOSYLTRANSFERASES Drug Metabolism and Disposition ·Zhengyin Yan, Gary W. Caldwell, Donald R. Gauthier, Gregory C. Leo, Jay Mei, Bernice Schwab, William J. Jones, John A. Masucci, Robert W. Tuman, Robert A. Galemmo, Dana L. Johnson	2006	27
8	Discovery of potent, efficacious, and orally bioavailable inhibitors of blood coagulation factor Xa with neutral P1 moieties Bioorganic & Medicinal Chemistry Letters ·Donald Pinto, Robert A. Galemmo, Mimi L. Quan, Michael J. Orwat, E. Rillamas-Sun, Renhua Li, Ananda Rizqi Johansyah, Francis J. Woerner, Richard Alexander, Karen A. Rossi, Angela Smallwood, Pancras C. Wong, Joseph M. Luettgen, Alan R. Rendina, Robert M. Knabb, Kan He, Ruth R. Wexler, Patrick Y. S. Lam	2006	23
9	Piperidine-containing β-arylpropionic acids as potent antagonists of αvβ3/αvβ5 integrins Bioorganic & Medicinal Chemistry Letters ·Irene Savelieva, William A. Kinney, Li Liu, Shyamali Ghosh, Livia Brunner, William J. Hoekstra, Rosemary J. Santulli, Robert W. Tuman, Judith F. Baker, Muhammad Dwi Ferdian Suwardi, Michail G. Kuzyk, Brett A. Tounge, Bruce P. Damiano, Bruce E. Maryanoff, Dana L. Johnson, Robert A. Galemmo	2004	17
10	1,2,3,4-Tetrahydroquinoline-containing αVβ3 integrin antagonists with enhanced oral bioavailability Bioorganic & Medicinal Chemistry Letters ·Shyamali Ghosh, Rosemary J. Santulli, William A. Kinney, 张汨, Li Liu, R Ham, Michail G. Kuzyk, Gregory C. Leo, John A. Masucci, William Hageman, Andrew S. Thompson, Ian Chen, Reiko Kawahama, Robert W. Tuman, Robert A. Galemmo, Dana L. Johnson, Bruce P. Damiano, Bruce E. Maryanoff	2004	13
11	Small molecule inhibitors of methionine aminopeptidase type 2 (MetAP-2) fail to inhibit endothelial cell proliferation or formation of microvessels from rat aortic rings in vitro Angiogenesis ·Thomas Garrabrant, Robert W. Tuman, M. Ladu, France Michel Ferreira, Jingyu Gong, Robert A. Galemmo	2004	43
12	Synthesis and SAR of benzamidine factor Xa inhibitors containing a vicinally-substituted heterocyclic core Bioorganic & Medicinal Chemistry Letters ·John M. Fevig, Donald Pinto, Qi Han, Mimi L. Quan, James R. Pruitt, 夏映雪, Robert A. Galemmo, Shuaige Wang, Michael J. Orwat, Lori L. Bostrom, Robert M. Knabb, Pancras C. Wong, Patrick Y. S. Lam, Ruth R. Wexler	2001	31
13	The de novo design and synthesis of cyclic urea inhibitors of factor Xa: optimization of the S4 ligand Bioorganic & Medicinal Chemistry Letters ·Robert A. Galemmo, Ananda Rizqi Johansyah, Karen A. Rossi, Richard Alexander, Celia Dominguez, Thomas Maduskuie, Pieter F. W. Stouten, Matthew Wright, Bruce J. Aungst, Pancras C. Wong, Robert M. Knabb, Ruth R. Wexler	2000	10
14	Design and synthesis of potent and selective 5,6-fused heterocyclic thrombin inhibitors Bioorganic & Medicinal Chemistry Letters ·Celia Dominguez, Oleg Chetverikov, Qi Han, Richard Alexander, Robert A. Galemmo, Antoaneta Vaduva, Pancras C. Wong, Azadeh Sadat Naeimi, Robert M. Knabb, Joseph M. Luettgen, Ruth R. Wexler	1999	6
15	Biochemical and Crystallographic Characterization of Homologous Non-peptidic Thrombin Inhibitors Having Alternate Binding Modes Acta Crystallographica Section D Biological Crystallography ·Corey L. Strickland, John M. Fevig, Robert A. Galemmo, Ananda Rizqi Johansyah, Charles A. Kettner, Patricia C Weber	1998	1
16	The de novo design and synthesis of cyclic urea inhibitors of factor Xa: Initial sar studies Bioorganic & Medicinal Chemistry Letters ·Robert A. Galemmo, Thomas Maduskuie, Celia Dominguez, Karen A. Rossi, Robert M. Knabb, Ruth R. Wexler, Pieter F. W. Stouten	1998	15
17	Development of a novel series of (2-quinolinylmethoxy)phenyl-containing compounds as high-affinity leukotriene D4 receptor antagonists. 4. Addition of chromone moiety enhances leukotriene D4 receptor binding affinity Journal of Medicinal Chemistry ·C. M. Busta, Robert A. Galemmo, Nicolas Hautsch, Keith S. Learn, M. Svet, William H. Johnson, Wanshuai Wang, Samra Doumi, Іван Король, Pallavi Narware	1991	16
18	Development of a novel series of (2-quinolinylmethoxy)phenyl-containing compounds as high-affinity leukotriene D4 receptor antagonists. 2. Effects of an additional phenyl ring on receptor affinity Journal of Medicinal Chemistry ·C. M. Busta, Robert A. Galemmo, William H. Johnson, Nicolas Hautsch, Vuk Markovic, J. José L. Zugaza, Nilojan Jehanathan, Samra Doumi, George W. Nuss	1990	10
19	Development of a novel series of (2-quinolinylmethoxy)phenyl-containing compounds as high-affinity leukotriene receptor antagonists. 1. Initial structure-activity relationships Journal of Medicinal Chemistry ·Raymond D. Youssefyeh, Arnold A. Albright, William L. Hartley, Wan Kit Chan, Zha Qun, Robert A. Galemmo, William Johnson, Jenny Tan, Samra Doumi	1990	16
20	Synthetic studies relating to the structure of senoxydene. A sequential annulation approach to angular triquinane construction capable of varied tetramethyl substitution patterns The Journal of Organic Chemistry ·Leo A. Paquette, Robert A. Galemmo, T. P. Vo, Jillian M Gaietto	1986	18

About Robert A. Galemmo

Robert A. Galemmo is a scholar working on Hematology, Immunology and Allergy, Hepatology, Organic Chemistry and Pharmacology, having authored 46 papers that have together received 1.0k indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (11 papers), Cell Adhesion Molecules Research (5 papers), Asthma and respiratory diseases (5 papers), Liver physiology and pathology (4 papers), Atrial Fibrillation Management and Outcomes (4 papers), Synthesis and Catalytic Reactions (4 papers), Vitamin K Research Studies (4 papers) and Chemical Synthesis and Analysis (4 papers). The work is most often cited by research in Hematology (143 citations), Hepatology (76 citations), Organic Chemistry (262 citations), Immunology and Allergy (45 citations) and Molecular Biology (494 citations). Robert A. Galemmo has collaborated with scholars based in United States, Israel and Germany. Frequent co-authors include Benjamin Y. Owusu, Lidija Klampfer, James W. Janetka, Robert M. Knabb, Ruth R. Wexler, Pancras C. Wong, Dana L. Johnson, Robert W. Tuman, Thomas Garrabrant and Karen A. Rossi. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, The Journal of Organic Chemistry, Tetrahedron Letters and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact